1
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Condition(s):Acute Coronary SyndromeLast Updated:February 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Coronary SyndromeLast Updated:February 20, 2024Recruiting
Condition(s):Covid19Last Updated:December 7, 2022Completed
Condition(s):Acute Coronary SyndromeLast Updated:October 12, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.